Boma Achenimie 
The National Agency for Food and Drug Administration (NAFDAC) on Monday reacted to an alleged spread of low-quality paracetamol in Nigeria’s pharmaceutical market.
Speaking in a statement issued by NAFDAC’s media consultant, Sayo Akintola, clarified that there is no evidence of the circulation of low-quality paracetamol in the country.
The agency, however, assured the public of its vigilance in safeguarding the Nation’s health.
READ ALSO:
- NAFDAC Apprehends 66 Drug Peddlers In 10 Months
- NAFDAC To Review Sanction On Exporters Of Substandard Products
- NAFDAC Approves Use Of Gardasil Vaccines For Cervical Cancer
“We have received a copy of the publication of the research findings on the subject, and we wish to state categorically that the report is misleading and the science is questionable.
“We do a yearly post-marketing survey of medicines to ensure that the quality and safety are maintained. Where there is a deviation from this, i.e., when we find any regulated product to be substandard or falsified, NAFDAC regularly issues public alerts or recalls.
“NAFDAC wishes to reassure the public that the agency is very vigilant in safeguarding the Nation’s health”, he stated.
